Early follow-up of outpatients with oral anticancer therapy in the ONCORAL multidisciplinary community-hospital program.

Claire LattardChloé HerledanThibaut ReverdyGabriel AntherieuAnne-Gaelle CaffinMarie-Anne CerfonMagali MaireMarine RivatStéphanie FranceHervé GhesquièresBenoit YouGilles FreyerFlorence Ranchon Catherine Rioufol

Published in: The oncologist (2024)

In these ambulatory cancer patients, the interest in tailored monitoring of DRPs as a whole, including the prevention and management of drug interactions in addition to symptoms and adverse effects, is highlighted.

Keyphrases

quality improvement
healthcare
blood pressure
mental health
smoking cessation
acute care
adverse drug
stem cells
sleep quality
emergency department
cell therapy
drug induced